(Total Views: 1062)
Posted On: 01/07/2020 5:01:05 PM
Post# of 416
NetworkNewsBreaks – Endonovo Therapeutics, Inc. (ENDVD) Announces Issuance of U.S. Patent, Expansion of its SofPulse(R) Intellectual Property Portfolio
Endonovo Therapeutics (OTCQB: ENDVD) today announced that the United States Patent and Trademark Office (“USPTO”) has issued U.S. Patent No. 15217855, which is directed to the usage of an Apparatus and Method for Electromagnetic Treatment of Neurological Injury or Condition Caused by a Stroke. “We are extremely pleased with the continued development and expansion of our patent portfolio,” Endonovo Therapeutics CEO Alan Collier said in the news release. “This new issuance continues to expand the breadth and depth of our SofPulse(R) unit intellectual property portfolio and the issuance of this patent is another step in the development of a robust patent portfolio relating to SofPulse(R).”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Endonovo Therapeutics (OTCQB: ENDVD) today announced that the United States Patent and Trademark Office (“USPTO”) has issued U.S. Patent No. 15217855, which is directed to the usage of an Apparatus and Method for Electromagnetic Treatment of Neurological Injury or Condition Caused by a Stroke. “We are extremely pleased with the continued development and expansion of our patent portfolio,” Endonovo Therapeutics CEO Alan Collier said in the news release. “This new issuance continues to expand the breadth and depth of our SofPulse(R) unit intellectual property portfolio and the issuance of this patent is another step in the development of a robust patent portfolio relating to SofPulse(R).”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)
